Programmed death-ligand 1 positivity can predict improved survival and a lower risk of brain metastasis in patients with resectable small cell lung cancer

The present study aimed to investigate the expression of programmed death-ligand 1 (PD-L1) in resectable small cell lung cancer (SCLC) and investigate its predictive value for survival and brain metastasis (BM). Postoperative SCLC specimens were immunostained with the SP142 antibody against PD-L1. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin, Lu, Zhong, Wang, Wenhao, Sun, Xiumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036471/
https://www.ncbi.nlm.nih.gov/pubmed/30008941
http://dx.doi.org/10.3892/ol.2018.8895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036471/
https://www.ncbi.nlm.nih.gov/pubmed/30008941
http://dx.doi.org/10.3892/ol.2018.8895

Ejemplares similares